ACTINIUM PHARMACEUTICALS, INC. Earnings Per Share, Basic and Diluted
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Earnings Per Share, Basic and Diluted of -$1.20 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-25.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-25
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.36.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.30.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.25.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.29.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2021 was -$1.20.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.83.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2019 was -$4.40.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.22.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$0.66 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$0.91 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$1.20 10-K · filed 2022-03-25 | ||||
| 2021-09-30 | -$0.30 10-Q · filed 2021-11-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.84 10-Q · filed 2021-11-12 | -$1.22 derived: net income ÷ weighted average shares · filed 2022-03-25 | ||||
| 2021-06-30 | -$0.25 10-Q · filed 2021-07-30 | -$0.54 10-Q · filed 2021-07-30 | -$0.92 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$1.27 derived: net income ÷ weighted average shares · filed 2022-03-25 | ||||
| 2021-03-31 | -$0.29 10-Q · filed 2021-05-14 | -$0.68 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$1.04 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$1.43 derived: net income ÷ weighted average shares · filed 2022-03-25 | ||||
| 2020-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$0.76 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$1.16 derived: net income ÷ weighted average shares · filed 2022-03-25 | -$1.83 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | -$0.36 10-Q · filed 2021-11-12 | -$0.76 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$1.46 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | -$0.41 10-Q · filed 2021-07-30 | -$1.20 10-Q · filed 2021-07-30 | ||||||
| 2020-03-31 | -$0.98 10-Q · filed 2021-05-14 | -$0.03 10-Q · filed 2020-06-29 | ||||||
| 2019-12-31 | -$0.84 derived: net income ÷ weighted average shares · filed 2021-03-31 | -$2.05 derived: net income ÷ weighted average shares · filed 2021-03-31 | -$3.04 derived: net income ÷ weighted average shares · filed 2021-03-31 | -$4.40 10-K · filed 2021-03-31 | -$0.15 10-K · filed 2020-05-08 | |||
| 2019-09-30 | -$1.21 10-Q · filed 2020-10-23 | -$0.04 10-Q · filed 2019-11-12 | -$2.22 derived: net income ÷ weighted average shares · filed 2020-10-23 | -$3.60 10-Q · filed 2020-10-23 | -$0.12 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | -$1.00 10-Q · filed 2020-08-14 | -$0.03 10-Q · filed 2019-08-09 | -$2.39 10-Q · filed 2020-08-14 | -$0.08 10-Q · filed 2019-08-09 | ||||
| 2019-03-31 | -$0.05 10-Q · filed 2020-06-29 | |||||||
| 2018-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2020-05-08 | -$0.11 derived: net income ÷ weighted average shares · filed 2020-05-08 | -$0.15 derived: net income ÷ weighted average shares · filed 2020-05-08 | -$0.22 10-K · filed 2020-05-08 | ||||
| 2018-09-30 | -$0.06 10-Q · filed 2019-11-12 | -$0.10 derived: net income ÷ weighted average shares · filed 2019-11-12 | -$0.17 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | -$0.04 10-Q · filed 2019-08-09 | -$0.11 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | -$0.07 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | -$0.40 10-K · filed 2019-03-15 | |||||||
| 2017-09-30 | -$0.09 10-Q · filed 2018-11-09 | -$0.34 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | -$0.12 10-Q · filed 2018-08-09 | -$0.26 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | -$0.14 10-Q · filed 2018-05-10 | |||||||
| 2016-12-31 | -$0.50 10-K · filed 2019-03-15 | |||||||
| 2016-09-30 | -$0.14 10-Q · filed 2017-11-03 | -$0.38 10-Q · filed 2017-11-03 | ||||||
| 2016-06-30 | -$0.14 10-Q · filed 2017-08-04 | -$0.24 10-Q · filed 2017-08-04 | ||||||
| 2016-03-31 | -$0.10 10-Q · filed 2017-05-15 | |||||||
| 2015-12-31 | -$0.55 10-K · filed 2018-03-16 | |||||||
| 2015-09-30 | -$0.10 10-Q · filed 2015-10-30 | -$0.39 10-Q · filed 2015-10-30 | ||||||
| 2015-03-31 | -$0.09 10-Q · filed 2016-05-10 | |||||||
| 2014-12-31 | -$0.90 10-K · filed 2017-03-16 | |||||||
| 2014-09-30 | -$0.21 10-Q · filed 2015-10-30 | -$0.73 10-Q · filed 2015-10-30 | ||||||
| 2014-03-31 | -$0.66 10-Q · filed 2015-05-08 | |||||||
| 2013-12-31 | -$0.47 10-K · filed 2016-03-11 | |||||||
| 2013-09-30 | -$0.06 10-Q · filed 2014-10-31 | -$0.22 10-Q · filed 2014-10-31 | ||||||
| 2013-06-30 | -$0.13 10-Q · filed 2013-08-13 | -$0.16 10-Q · filed 2013-08-13 | ||||||
| 2013-03-31 | -$0.03 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | -$7.58 10-K · filed 2014-02-28 | |||||||
| 2012-09-30 | -$3.76 10-Q · filed 2013-11-14 | -$6.84 10-Q · filed 2013-11-14 | -$0.01 10-Q · filed 2012-11-14 | |||||
| 2012-06-30 | -$0.09 10-Q · filed 2013-08-13 | -$0.15 10-Q · filed 2013-08-13 | -$0.01 10-Q/A · filed 2012-08-29 | |||||
| 2012-03-31 | -$0.07 10-Q · filed 2013-05-15 | -$0.01 10-Q · filed 2012-04-23 | ||||||
| 2011-12-31 | -$0.01 10-Q · filed 2012-04-23 | -$4.30 10-K · filed 2013-03-29 | $0.01 10-K · filed 2012-04-12 | |||||
| 2011-09-30 | $0.01 10-Q · filed 2012-11-14 | -$0.01 10-Q · filed 2011-11-14 | ||||||
| 2011-06-30 | $0.01 10-Q/A · filed 2012-08-29 | -$0.01 10-Q · filed 2011-08-12 | ||||||
| 2010-12-31 | $0.01 10-K · filed 2012-04-12 | |||||||
| 2010-09-30 | -$0.01 10-Q · filed 2011-11-14 | |||||||
| 2010-06-30 | -$0.01 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |